7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 
      
    		                                                                                               
      operating activities
    		                                                                                               
      net income
    		1,163,000,000 831,000,000 1,306,000,000 928,000,000 287,000,000 960,000,000 830,000,000 630,000,000 703,000,000 997,000,000 826,000,000 1,120,000,000 967,000,000 809,000,000 405,000,000 39,000,000 310,000,000 533,000,000 713,000,000 -6,174,000,000 627,000,000 494,000,000 1,078,000,000 242,000,000 -677,000,000 477,000,000 -744,000,000 526,000,000 553,000,000 -80,000,000 -1,085,000,000 961,000,000 56,000,000 365,000,000 3,623,000,000 646,000,000 324,000,000 560,000,000 444,000,000 647,000,000 630,000,000 589,000,000 144,000,000 511,000,000 477,000,000 411,000,000 366,000,000 64,000,000 404,000,000 424,000,000 259,000,000 298,000,000 401,000,000 380,000,000 521,000,000 300,000,000 296,000,000 286,000,000 422,000,000 155,000,000 327,000,000 298,000,000 348,000,000 326,000,000 301,000,000 288,000,000 281,000,000 -20,000,000 327,000,000 235,000,000 307,000,000 201,000,000 247,000,000 235,000,000 257,000,000 243,000,000 229,000,000 184,000,000 220,000,000     -665,400,000 86,100,000 163,600,000        117,300,000  
      adjustments to reconcile to net cash from operating activities:
    		                                                                                               
      depreciation
    		62,000,000 62,000,000 60,000,000 58,000,000 61,000,000 63,000,000 62,000,000 62,000,000 65,000,000 64,000,000 63,000,000 61,000,000 63,000,000 61,000,000 64,000,000 67,000,000 68,000,000 80,000,000 84,000,000 83,000,000 79,000,000 75,000,000                                                             28,400,000 27,600,000 28,100,000 27,400,000 31,000,000 24,300,000 24,400,000 25,100,000 25,000,000 24,000,000 24,700,000 27,500,000  
      amortization
    		126,000,000 95,000,000 91,000,000 95,000,000 102,000,000 106,000,000 98,000,000 97,000,000 92,000,000 95,000,000 98,000,000 87,000,000 88,000,000 87,000,000 98,000,000 118,000,000 127,000,000 138,000,000 137,000,000 144,000,000 143,000,000 142,000,000                                                             36,700,000 34,700,000 34,100,000 33,900,000 35,800,000 33,100,000 30,500,000 27,900,000 27,900,000 26,000,000 25,400,000 23,200,000  
      asset impairment charges
    		2,000,000 2,000,000  7,000,000                                                                                            
      deferred taxes
    		-33,000,000 -8,000,000 -260,000,000 25,000,000 97,000,000 28,000,000 -51,000,000 -281,000,000 -36,000,000 -235,000,000 -75,000,000 -115,000,000 61,000,000 109,000,000 22,000,000 30,000,000 -54,000,000 36,000,000 612,000,000 -1,485,000,000 -63,000,000 28,000,000 45,000,000 -7,000,000 -396,000,000 16,000,000 19,000,000 110,000,000 15,000,000 45,000,000 -21,000,000 -889,000,000 -43,000,000 85,000,000 760,000,000 212,000,000 -121,000,000 31,000,000 34,000,000 7,000,000 0 23,000,000 116,000,000 -55,000,000 -25,000,000 135,000,000  -66,000,000                 44,000,000 60,000,000   52,000,000 10,000,000 6,000,000 151,000,000 145,000,000 -104,000,000 90,000,000 7,000,000 12,000,000 58,000,000 160,000,000 132,000,000 78,000,000 33,000,000              
      credits associated with last-in, first-out inventory method
    		         32,000,000  5,000,000 -23,000,000 -13,000,000 56,000,000 -33,000,000 -23,000,000 -23,000,000 77,000,000 -11,000,000 -52,000,000 -52,000,000 -138,000,000 -66,000,000 -33,000,000 -15,000,000 -146,000,000 -21,000,000                                                                    
      non-cash operating lease expense
    		70,000,000 70,000,000 66,000,000 66,000,000 56,000,000 57,000,000 42,000,000 64,000,000 64,000,000 58,000,000 66,000,000 57,000,000 63,000,000 63,000,000 43,000,000 46,000,000 62,000,000 90,000,000 70,000,000 92,000,000 89,000,000 83,000,000 90,000,000 96,000,000                                                                        
      gain from sales of businesses and investments
    		-102,000,000 17,000,000 -86,000,000 660,000,000 -3,000,000 -86,000,000 0 -1,000,000 3,000,000 -19,000,000 4,000,000 -67,000,000 -115,000,000 -33,000,000 -15,000,000 -16,000,000                                                                                
      canadian businesses held for sale
    		                                                                                               
      benefit from bad debts
    		36,000,000 196,000,000 14,000,000 25,000,000 -184,000,000 15,000,000 39,000,000                                                                        -6,000,000    -1,900,000 4,700,000 6,100,000 6,700,000 100,000 14,500,000 37,200,000 2,600,000 11,200,000 10,300,000 27,000,000 20,000,000  
      other non-cash items
    		112,000,000 57,000,000 213,000,000 37,000,000 105,000,000 69,000,000 96,000,000 -177,000,000 273,000,000 41,000,000 77,000,000 64,000,000 55,000,000 102,000,000 49,000,000 71,000,000 187,000,000 194,000,000 121,000,000 50,000,000 8,000,000 9,000,000 73,000,000 398,000,000 23,000,000 121,000,000 68,000,000 122,000,000 -59,000,000 -79,000,000 130,000,000 -104,000,000 -36,000,000 8,000,000 38,000,000 45,000,000 -24,000,000 29,000,000 -31,000,000 132,000,000 38,000,000 -31,000,000 100,000,000 -71,000,000 4,000,000 14,000,000 47,000,000 21,000,000 30,000,000 32,000,000 3,000,000 33,000,000   -36,000,000 50,000,000 13,000,000 39,000,000 -46,000,000 -23,000,000 69,000,000 12,000,000 -13,000,000 -3,000,000 -22,000,000 18,000,000 -5,000,000 2,000,000 0 -1,000,000 -29,000,000 -14,000,000 37,000,000 -18,000,000 -47,000,000 -14,000,000 -27,000,000 12,000,000 6,000,000 0 3,000,000 -1,000,000 5,200,000 -3,600,000 -1,400,000 -1,000,000 34,600,000 400,000 -18,500,000 -1,900,000 -800,000 10,300,000 -6,100,000 5,700,000  
      changes in assets and liabilities:
    		                                                                                               
      receivables
    		-207,000,000 -2,089,000,000 129,000,000 -565,000,000 -1,398,000,000 -2,101,000,000 1,344,000,000 -1,091,000,000 -827,000,000 -2,380,000,000 1,111,000,000 -310,000,000 -299,000,000 -1,584,000,000 82,000,000 386,000,000 -1,266,000,000 -1,045,000,000 -355,000,000 519,000,000 -1,310,000,000 2,291,000,000 -1,450,000,000 -178,000,000 195,000,000 -1,061,000,000 576,000,000 162,000,000 -291,000,000 -1,414,000,000 2,221,000,000 -234,000,000 -449,000,000 -363,000,000 -108,000,000 3,000,000 -357,000,000 -300,000,000 -290,000,000 -630,000,000 -288,000,000 -749,000,000 11,000,000 -1,297,000,000 -836,000,000 -699,000,000 -20,000,000 -475,000,000 -245,000,000 -145,000,000 269,000,000 -162,000,000 -225,000,000 444,000,000 -195,000,000 -140,000,000 -240,000,000 -195,000,000 -475,000,000 -53,000,000 -317,000,000 172,000,000 282,000,000 -466,000,000 -250,000,000 301,000,000 173,000,000 -544,000,000 -26,000,000 -311,000,000 142,000,000 -268,000,000 27,000,000 -189,000,000 -77,000,000 -388,000,000 121,000,000 135,000,000 -85,000,000 -502,000,000 85,000,000 -23,000,000 -104,300,000 -62,200,000 -92,500,000 -65,900,000 -5,600,000 -322,200,000 87,600,000 -464,500,000 -796,700,000 593,100,000 -245,100,000 -192,900,000  
      inventories
    		-1,228,000,000 -1,971,000,000 864,000,000 176,000,000 1,132,000,000 -4,442,000,000 1,090,000,000 -35,000,000 -1,523,000,000 -826,000,000 931,000,000 -737,000,000 -498,000,000 -955,000,000 490,000,000 -495,000,000 -263,000,000 -901,000,000 -230,000,000 -650,000,000 -1,634,000,000 238,000,000 313,000,000 -1,020,000,000 186,000,000 145,000,000 388,000,000 -358,000,000 -284,000,000 -114,000,000 952,000,000 -193,000,000 -1,158,000,000 -59,000,000 694,000,000 -536,000,000 283,000,000 -121,000,000 1,146,000,000 -928,000,000 -834,000,000 -635,000,000 510,000,000 -1,493,000,000 -260,000,000 -901,000,000 186,000,000 -1,152,000,000 -175,000,000 -60,000,000 254,000,000 -329,000,000   322,000,000 -931,000,000 34,000,000 -303,000,000 345,000,000 -640,000,000 690,000,000 -28,000,000 -577,000,000 -229,000,000 66,000,000 -42,000,000 860,000,000 -321,000,000 103,000,000 -272,000,000 555,000,000 -1,166,000,000 -261,000,000 196,000,000 536,000,000 -829,000,000 -189,000,000 -446,000,000 944,000,000 -619,000,000 -9,000,000 262,000,000 814,600,000 -362,700,000 -535,500,000 -636,400,000 365,900,000 -147,200,000 -976,300,000 76,300,000 536,300,000 -547,200,000 179,700,000 -155,400,000  
      drafts and accounts payable
    		3,223,000,000 1,947,000,000 5,624,000,000 -3,544,000,000 1,605,000,000 4,616,000,000 424,000,000 -144,000,000 2,834,000,000 1,473,000,000 257,000,000 1,239,000,000 1,286,000,000 1,006,000,000 1,190,000,000 181,000,000 2,040,000,000 -609,000,000 2,507,000,000 65,000,000 2,909,000,000 -4,214,000,000 4,881,000,000 274,000,000 -1,330,000,000 127,000,000 1,801,000,000 -1,022,000,000 1,165,000,000 32,000,000 -932,000,000 -605,000,000 1,345,000,000 463,000,000 179,000,000 -281,000,000 623,000,000 1,549,000,000 1,607,000,000 -265,000,000 957,000,000 1,003,000,000 554,000,000 2,662,000,000 134,000,000 1,368,000,000 1,828,000,000 237,000,000 -245,000,000 592,000,000 956,000,000 -452,000,000 307,000,000 -936,000,000 391,000,000 756,000,000 435,000,000 445,000,000 481,000,000 469,000,000 -497,000,000 80,000,000 209,000,000 320,000,000 455,000,000 356,000,000 -573,000,000 367,000,000 -312,000,000 329,000,000 -299,000,000 270,000,000 689,000,000 102,000,000 -42,000,000 460,000,000 149,000,000 305,000,000 -122,000,000 124,000,000 1,060,000,000 48,000,000 -84,000,000 53,200,000 678,900,000 664,100,000 277,900,000 67,600,000 237,400,000 317,200,000      
      operating lease liabilities
    		-63,000,000 -89,000,000 -99,000,000 -109,000,000 -100,000,000 -96,000,000 -92,000,000 -81,000,000 -86,000,000 -80,000,000 -82,000,000 -82,000,000 -80,000,000 -94,000,000 -80,000,000 -90,000,000 -96,000,000 -90,000,000 -71,000,000 -106,000,000 -96,000,000 -89,000,000 -90,000,000 -98,000,000                                                                        
      taxes
    		-13,000,000 134,000,000 152,000,000 -143,000,000 66,000,000 -211,000,000 371,000,000 36,000,000 -312,000,000 236,000,000 -18,000,000 299,000,000 45,000,000 37,000,000 67,000,000 136,000,000 94,000,000 -54,000,000 -350,000,000 242,000,000 -134,000,000 76,000,000 -19,000,000 -59,000,000 -12,000,000 82,000,000 36,000,000 -32,000,000 -38,000,000 -61,000,000 -18,000,000 603,000,000 104,000,000 -18,000,000 94,000,000 -99,000,000 56,000,000 95,000,000 -192,000,000 -89,000,000 -2,000,000 205,000,000 -19,000,000 -137,000,000 68,000,000 -134,000,000 64,000,000 148,000,000 -27,000,000 33,000,000 8,000,000 29,000,000 25,000,000 -142,000,000         -7,000,000 35,000,000 43,000,000 17,000,000 -154,000,000 59,000,000 -14,000,000 62,000,000 112,000,000 32,000,000 -46,000,000 238,000,000 109,000,000 2,000,000 -7,000,000 40,000,000 -55,000,000 -27,000,000 -6,000,000 35,000,000 56,100,000 110,500,000 -4,200,000 -49,200,000 63,200,000 36,600,000 -42,900,000 4,700,000      
      litigation liabilities
    		  -15,000,000 0 -500,000,000 114,000,000 134,000,000 0   -67,000,000 -106,000,000 -545,000,000 -370,000,000 53,000,000 -5,000,000 77,000,000 74,000,000 0                                                                             
      other
    		-60,000,000 -165,000,000 -323,000,000 450,000,000 65,000,000 -473,000,000 -9,000,000 393,000,000 189,000,000 -536,000,000 43,000,000 116,000,000 83,000,000 -186,000,000 78,000,000 140,000,000 137,000,000 -149,000,000 108,000,000 196,000,000 357,000,000 -150,000,000 -25,000,000 -60,000,000 250,000,000 -173,000,000 229,000,000 66,000,000 43,000,000 -270,000,000 8,000,000 227,000,000 26,000,000 -39,000,000 -91,000,000 116,000,000 -117,000,000 -273,000,000 181,000,000 -38,000,000 139,000,000 -145,000,000 -123,000,000 322,000,000 103,000,000 -260,000,000 -61,000,000 312,000,000 120,000,000 -285,000,000 -10,000,000 242,000,000 3,000,000 -284,000,000 -62,000,000 183,000,000 38,000,000 -70,000,000 -48,000,000 38,000,000 -44,000,000 -90,000,000 119,000,000 87,000,000 -43,000,000 -142,000,000 66,000,000 95,000,000 -37,000,000 -141,000,000 -27,000,000 146,000,000 -34,000,000 -80,000,000 101,000,000 114,000,000 -6,000,000 -82,000,000 48,000,000 15,000,000 -18,000,000 -84,000,000 -7,000,000 54,700,000 78,700,000 -86,800,000 -66,600,000 42,000,000 57,300,000 -102,200,000 -33,400,000 56,600,000 18,400,000 -41,200,000 71,400,000 
      net cash from operating activities
    		2,420,000,000 -918,000,000 7,748,000,000 -2,383,000,000 2,100,000,000 -1,380,000,000 4,147,000,000 254,000,000 965,000,000 -1,052,000,000 3,325,000,000 1,668,000,000 1,107,000,000 -941,000,000 2,887,000,000 1,377,000,000 1,792,000,000 -1,622,000,000 3,370,000,000 1,213,000,000 1,021,000,000 -1,062,000,000 4,654,000,000 -121,000,000 -108,000,000 -51,000,000 3,895,000,000 -177,000,000 1,379,000,000 -1,061,000,000 3,022,000,000 -16,000,000 598,000,000 741,000,000 1,435,000,000 381,000,000 1,069,000,000 1,859,000,000 3,106,000,000 -685,000,000 797,000,000 454,000,000 1,883,000,000 1,064,000,000 -17,000,000 182,000,000 2,664,000,000 -341,000,000 97,000,000 716,000,000 2,207,000,000 -183,000,000 1,011,000,000 -552,000,000 1,234,000,000 321,000,000 1,069,000,000 326,000,000 1,000,000,000 540,000,000 270,000,000 528,000,000 591,000,000 192,000,000 626,000,000 907,000,000 617,000,000 186,000,000 234,000,000 314,000,000 916,000,000 -1,319,000,000 840,000,000 432,000,000 984,000,000 -130,000,000 390,000,000 295,000,000 1,267,000,000 -532,000,000 1,372,000,000 637,000,000    128,300,000          
      capex
    		-196,000,000 -189,000,000 -278,000,000 -196,000,000 -218,000,000 -167,000,000 -269,000,000 -154,000,000 -140,000,000 -124,000,000 -182,000,000 -154,000,000 -122,000,000 -100,000,000 -155,000,000 -101,000,000 -120,000,000 -159,000,000 -214,000,000 -162,000,000 -46,000,000 -117,000,000 -168,000,000 -154,000,000 -73,000,000 -111,000,000 -152,000,000 -157,000,000 -103,000,000 -145,000,000 -188,000,000 -137,000,000 -137,000,000 -118,000,000 -193,000,000 -129,000,000 -126,000,000 -114,000,000 -44,000,000 -49,000,000 -53,000,000 -43,000,000 -50,000,000 -38,000,000 -48,000,000 -33,000,000 -33,000,000 -42,000,000 -34,000,000 -32,000,000 -43,000,000 -36,000,000 -43,000,000 -38,000,000 -41,000,000 -36,000,000 -50,000,000 -51,000,000 -44,000,000 -36,000,000 -40,000,000 -35,000,000 -45,000,000 -38,000,000 -52,000,000 -44,000,000 -60,000,000 -47,000,000 -52,000,000 -38,000,000 -43,000,000 -40,000,000 -37,000,000 -41,000,000 -61,000,000 -33,000,000 -38,000,000 -48,000,000 -32,000,000 -62,000,000 -34,000,000 -32,000,000    -37,000,000          
      free cash flows
    		2,224,000,000 -1,107,000,000 7,470,000,000 -2,579,000,000 1,882,000,000 -1,547,000,000 3,878,000,000 100,000,000 825,000,000 -1,176,000,000 3,143,000,000 1,514,000,000 985,000,000 -1,041,000,000 2,732,000,000 1,276,000,000 1,672,000,000 -1,781,000,000 3,156,000,000 1,051,000,000 975,000,000 -1,179,000,000 4,486,000,000 -275,000,000 -181,000,000 -162,000,000 3,743,000,000 -334,000,000 1,276,000,000 -1,206,000,000 2,834,000,000 -153,000,000 461,000,000 623,000,000 1,242,000,000 252,000,000 943,000,000 1,745,000,000 3,062,000,000 -734,000,000 744,000,000 411,000,000 1,833,000,000 1,026,000,000 -65,000,000 149,000,000 2,631,000,000 -383,000,000 63,000,000 684,000,000 2,164,000,000 -219,000,000 968,000,000 -590,000,000 1,193,000,000 285,000,000 1,019,000,000 275,000,000 956,000,000 504,000,000 230,000,000 493,000,000 546,000,000 154,000,000 574,000,000 863,000,000 557,000,000 139,000,000 182,000,000 276,000,000 873,000,000 -1,359,000,000 803,000,000 391,000,000 923,000,000 -163,000,000 352,000,000 247,000,000 1,235,000,000 -594,000,000 1,338,000,000 605,000,000    91,300,000          
      investing activities
    		                                                                                               
      payments for property, plant, and equipment
    		-106,000,000 -111,000,000 -169,000,000 -126,000,000 -136,000,000 -106,000,000 -188,000,000 -90,000,000 -75,000,000 -78,000,000 -125,000,000 -108,000,000 -86,000,000 -71,000,000 -135,000,000 -67,000,000 -93,000,000 -93,000,000 -158,000,000 -119,000,000                                                                            
      capitalized software expenditures
    		-90,000,000 -78,000,000 -109,000,000 -70,000,000 -82,000,000 -61,000,000 -81,000,000 -64,000,000 -65,000,000 -46,000,000 -57,000,000 -46,000,000 -36,000,000 -29,000,000 -20,000,000 -34,000,000 -27,000,000 -66,000,000 -56,000,000 -43,000,000 -46,000,000 -45,000,000 -48,000,000 -38,000,000 -34,000,000 -24,000,000 -35,000,000 -26,000,000 -26,000,000 -44,000,000 -52,000,000 -32,000,000 -48,000,000 -43,000,000 -35,000,000 -34,000,000 -51,000,000 -38,000,000 -44,000,000 -49,000,000 -53,000,000 -43,000,000 -50,000,000 -38,000,000 -48,000,000 -33,000,000 -33,000,000 -42,000,000 -34,000,000 -32,000,000 -43,000,000 -36,000,000 -43,000,000 -38,000,000 -41,000,000 -36,000,000 -50,000,000 -51,000,000 -44,000,000 -36,000,000 -40,000,000 -35,000,000 -45,000,000 -38,000,000 -52,000,000 -44,000,000 -60,000,000 -47,000,000 -52,000,000 -38,000,000 -43,000,000 -40,000,000 -37,000,000 -41,000,000 -61,000,000 -33,000,000 -38,000,000 -48,000,000 -32,000,000 -62,000,000 -34,000,000 -32,000,000 -44,500,000 -25,800,000 -30,400,000 -37,000,000 -41,000,000 -35,600,000 -44,600,000 -50,800,000 -51,600,000 -45,500,000 -47,500,000 -39,100,000  
      acquisitions, net of cash, cash equivalents, and restricted cash acquired
    		-30,000,000 -3,359,000,000 -21,000,000 -2,000,000   -266,000,000    -11,000,000 -833,000,000 -22,000,000 -1,000,000 0 -2,000,000 -3,000,000 -1,000,000 -2,000,000 -25,000,000                                                                            
      proceeds from sales of businesses and investments
    		129,000,000 4,000,000 96,000,000 -10,000,000 3,000,000 90,000,000 0 -3,000,000 11,000,000 39,000,000 3,000,000 578,000,000 256,000,000 240,000,000 381,000,000 18,000,000 96,000,000 83,000,000 75,000,000 316,000,000 2,000,000 7,000,000                                                                          
      net cash from investing activities
    		-24,000,000 -3,564,000,000 -224,000,000 -136,000,000 -286,000,000 -87,000,000 -577,000,000 -180,000,000 -166,000,000 -149,000,000 -244,000,000 -414,000,000 77,000,000 39,000,000 183,000,000 -115,000,000 -58,000,000 -99,000,000 -205,000,000 68,000,000 -148,000,000 -130,000,000 -170,000,000 -124,000,000 -156,000,000 -129,000,000 -230,000,000 -168,000,000 -108,000,000 -875,000,000 -1,039,000,000 -87,000,000 -267,000,000 -129,000,000 -177,000,000 -2,273,000,000 -192,000,000 -1,154,000,000 -1,329,000,000 -159,000,000 -52,000,000 -17,000,000 -238,000,000 -132,000,000 -195,000,000 -112,000,000 -4,624,000,000 -148,000,000 -90,000,000 -184,000,000 -1,425,000,000 -433,000,000 -201,000,000 -150,000,000 -1,072,000,000 -81,000,000 -195,000,000 -154,000,000 -158,000,000 -371,000,000 -16,000,000 -79,000,000 -106,000,000 -11,000,000 -106,000,000 -86,000,000 -195,000,000 -79,000,000 -91,000,000 -362,000,000 -119,000,000 342,000,000 -138,000,000 -90,000,000 -1,951,000,000 -57,000,000 109,000,000 -204,000,000 -1,043,000,000 -124,000,000 -567,000,000 -91,000,000              
      financing activities
    		                                                                                               
      proceeds from short-term borrowings
    		  3,691,000,000 4,519,000,000 5,515,000,000 1,361,000,000 15,194,000,000 2,770,000,000 1,935,000,000 65,000,000 7,350,000,000 1,000,000,000   7,550,000,000 622,000,000   868,000,000 152,000,000 0 5,303,000,000 5,585,000,000 7,182,000,000 6,060,000,000 2,610,000,000 6,873,000,000 10,657,000,000 10,699,000,000 9,036,000,000 7,843,000,000 4,235,000,000 6,182,000,000 2,282,000,000 5,491,000,000 2,793,000,000 3,000,000 7,000,000 29,000,000 31,000,000 970,000,000 531,000,000 649,000,000 661,000,000 873,000,000 917,000,000 5,995,000,000 0 50,000,000 100,000,000 1,100,000,000 0           0 0   28,000,000 70,000,000                            
      repayments of short-term borrowings
    		  -6,116,000,000 -2,094,000,000 -5,515,000,000 -1,361,000,000 -15,412,000,000 -2,552,000,000 -1,935,000,000 -65,000,000 -7,967,000,000 -383,000,000   -7,922,000,000 -250,000,000   -1,020,000,000 0 0 -5,303,000,000 -7,694,000,000 -5,621,000,000 -5,512,000,000 -2,610,000,000 -7,922,000,000 -11,004,000,000 -11,337,000,000 -7,005,000,000 -8,592,000,000 -3,790,000,000 -5,880,000,000 -2,463,000,000 -6,719,000,000 -1,388,000,000 -3,000,000 -14,000,000 -20,000,000 -167,000,000 -967,000,000 -534,000,000 -825,000,000 -755,000,000 -813,000,000 -759,000,000 -5,972,000,000 0 -50,000,000 -100,000,000 -1,100,000,000 0 -1,125,000,000 -400,000,000         0 0 0 -6,000,000 -28,000,000 -70,000,000 -2,974,000,000 -558,000,000                          
      proceeds from issuances of long-term debt
    		0 1,990,000,000 0 0   0 0 0 991,000,000 498,000,000    0 0   0        0                -8,000,000 4,000,000 1,000,000 6,000,000     906,000,000                                             
      repayments of long-term debt
    		  -9,000,000 -9,000,000   -8,000,000 -9,000,000 -3,000,000 -268,000,000 -862,000,000 -408,000,000 -2,000,000 -2,000,000 -2,000,000 -10,000,000 -1,634,000,000 -2,000,000 -10,000,000 -1,025,000,000 -3,000,000 -2,000,000     -1,098,000,000 -9,000,000 -3,000,000 -2,000,000 -1,742,000,000 0 -4,000,000 -541,000,000 -1,209,000,000 -386,000,000 -5,000,000 -1,000,000 -602,000,000 -498,000,000 -402,000,000 -96,000,000 -113,000,000 -7,000,000 -3,000,000 -230,000,000     -1,139,000,000                                             
      common stock transactions:
    		                                                                                               
      issuances
    		28,000,000 22,000,000 28,000,000 19,000,000 32,000,000 22,000,000 41,000,000 21,000,000 27,000,000 27,000,000 20,000,000 16,000,000 36,000,000 91,000,000 46,000,000 63,000,000 40,000,000 71,000,000 37,000,000 16,000,000 18,000,000 21,000,000 24,000,000 11,000,000 56,000,000 22,000,000 29,000,000 8,000,000 16,000,000 22,000,000 18,000,000 31,000,000 56,000,000 27,000,000 31,000,000 14,000,000 39,000,000 36,000,000 26,000,000 25,000,000 34,000,000 38,000,000 37,000,000 49,000,000 32,000,000 34,000,000 27,000,000 31,000,000 69,000,000 50,000,000 54,000,000 32,000,000 37,000,000 43,000,000             20,000,000 12,000,000 35,000,000 30,000,000 57,000,000 114,000,000 34,000,000 149,000,000 160,000,000 48,000,000 131,000,000 60,000,000 133,000,000 153,000,000 127,000,000 155,000,000 106,200,000   83,000,000 10,800,000 24,200,000 22,900,000 34,700,000 8,900,000 23,200,000 7,300,000 39,400,000  
      share repurchases
    		-818,000,000 -581,000,000 -300,000,000 -827,000,000 -1,492,000,000 -527,000,000 -678,000,000 -842,000,000 -809,000,000 -696,000,000 -138,000,000 -2,016,000,000 -484,000,000 -1,000,000,000 -1,530,000,000 -714,000,000 -264,000,000 -1,008,000,000                                                     -772,000,000 -231,000,000 -428,000,000 -267,000,000 -247,000,000 -98,000,000 -375,000,000 -283,000,000 -379,000,000 -289,000,000 -224,000,000 -66,000,000     -41,500,000 -40,000,000 0 -75,300,000 0     
      dividends paid
    		-89,000,000 -90,000,000 -91,000,000 -92,000,000 -80,000,000 -82,000,000 -82,000,000 -83,000,000 -75,000,000 -74,000,000 -76,000,000 -77,000,000 -68,000,000 -71,000,000 -71,000,000 -72,000,000 -65,000,000 -69,000,000 -67,000,000 -69,000,000 -66,000,000 -74,000,000 -72,000,000 -74,000,000 -73,000,000 -75,000,000 -76,000,000 -77,000,000 -68,000,000 -71,000,000 -70,000,000 -71,000,000 -59,000,000 -62,000,000 -61,000,000 -63,000,000 -63,000,000 -66,000,000 -65,000,000 -65,000,000 -55,000,000 -59,000,000 -56,000,000 -56,000,000 -56,000,000 -59,000,000 -60,000,000 -55,000,000 -46,000,000 -53,000,000 -47,000,000 -47,000,000 -47,000,000 -53,000,000 -49,000,000 -49,000,000 -50,000,000 -47,000,000 -45,000,000 -46,000,000 -47,000,000 -33,000,000 -33,000,000 -32,000,000 -32,000,000 -34,000,000 -33,000,000 -33,000,000 -33,000,000 -17,000,000 -17,000,000 -17,000,000 -18,000,000 -18,000,000 -18,000,000 -18,000,000 -18,000,000 -18,000,000 -18,000,000 -19,000,000 -18,000,000 -18,000,000 -17,900,000 -17,700,000 -17,500,000 -17,500,000 -17,500,000 -17,500,000 -17,300,000 -17,500,000 -17,400,000 -17,700,000 -17,300,000 -17,300,000  
      net cash from financing activities
    		-961,000,000 1,176,000,000 -2,855,000,000 1,298,000,000 -1,599,000,000 -809,000,000 -968,000,000 -622,000,000 -909,000,000 -843,000,000 -1,190,000,000 -1,425,000,000 -572,000,000 -1,181,000,000 -1,989,000,000 -438,000,000 -1,743,000,000 -2,151,000,000 -517,000,000 -775,000,000 -462,000,000 61,000,000 -2,480,000,000 949,000,000 -331,000,000 -872,000,000 -2,544,000,000 119,000,000 -1,343,000,000 1,541,000,000 -1,937,000,000 125,000,000 -141,000,000 -1,131,000,000 -924,000,000 -1,031,000,000 -32,000,000 -82,000,000 -1,206,000,000 -1,057,000,000 -987,000,000 -203,000,000 -716,000,000 -84,000,000 -1,000,000 -167,000,000 3,692,000,000 -36,000,000 36,000,000 -73,000,000 -1,038,000,000 515,000,000 -8,000,000 -425,000,000 -1,208,000,000 -12,000,000 -17,000,000 -668,000,000 -445,000,000 -20,000,000 -473,000,000 -903,000,000 -184,000,000 30,000,000 36,000,000 -303,000,000 527,000,000 -20,000,000 -199,000,000 -130,000,000 -871,000,000 -101,000,000 -405,000,000 -93,000,000 908,000,000 -54,000,000 -242,000,000 -233,000,000 -265,000,000 -157,000,000 -218,000,000 63,000,000 -162,200,000 9,300,000            
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    		-9,000,000 33,000,000 5,000,000 -22,000,000 6,000,000 -5,000,000 0 7,000,000 -3,000,000 2,000,000 10,000,000 -9,000,000 6,000,000 18,000,000 20,000,000 17,000,000 7,000,000 11,000,000 16,000,000 -14,000,000                                                                            
      change in cash, cash equivalents, and restricted cash classified as assets held for sale
    		                                                                                               
      net decrease in cash, cash equivalents, and restricted cash
    		1,426,000,000 -3,273,000,000  -1,229,000,000 207,000,000 -2,281,000,000  -541,000,000 -113,000,000 -2,042,000,000  -180,000,000 618,000,000 -1,595,000,000  626,000,000 -2,000,000 -3,861,000,000  492,000,000                                                                            
      cash, cash equivalents, and restricted cash at beginning of period
    		0 5,956,000,000  0 0 4,585,000,000  0 0 4,679,000,000  0 0 3,935,000,000  0 0 6,396,000,000  0                                                                            
      cash, cash equivalents, and restricted cash at end of period
    		1,426,000,000 2,683,000,000  -1,229,000,000 207,000,000 2,304,000,000  -541,000,000 -113,000,000 2,637,000,000  -180,000,000 618,000,000 2,340,000,000  626,000,000 -2,000,000 2,535,000,000  492,000,000                                                                            
      less: restricted cash at end of period included in prepaid expenses and other
    		160,000,000 -265,000,000  -149,000,000 0 -2,000,000    -1,000,000  38,000,000 65,000,000 -107,000,000  -23,000,000 -270,000,000 -112,000,000  -6,000,000 102,000,000 -251,000,000                                                                          
      cash and cash equivalents at end of period
    		1,586,000,000 2,418,000,000  -1,378,000,000 207,000,000 2,302,000,000  -542,000,000 -112,000,000 2,636,000,000  -142,000,000 683,000,000 2,233,000,000  603,000,000 -272,000,000 2,423,000,000  486,000,000 478,000,000 2,613,000,000          56,000,000 224,000,000 2,339,000,000  -3,030,000,000 805,000,000 4,659,000,000  -1,953,000,000 -276,000,000 5,635,000,000  783,000,000 -301,000,000 4,105,000,000  -529,000,000 55,000,000 2,905,000,000  -105,000,000 818,000,000 2,013,000,000  248,000,000 827,000,000 3,116,000,000  163,000,000 -215,000,000 3,265,000,000  213,000,000 571,000,000 2,644,000,000  52,000,000 -64,000,000 1,187,000,000  -1,082,000,000 315,000,000 2,203,000,000  -241,000,000 254,000,000 2,000,000,000  -813,000,000 587,000,000 2,409,000,000  36,700,000 159,500,000 836,700,000  -61,100,000 -183,600,000 445,200,000      
      charges associated with last-in, first-out inventory method
    		 -7,000,000                                                                                              
      long-lived asset impairment charges
    		     3,000,000 15,000,000 0 0 28,000,000  2,000,000      104,000,000                                                                              
      charges (credits) associated with last-in, first-out inventory method
    		    -2,000,000 -2,000,000 -246,000,000 2,000,000                                                                                        
      changes in assets and liabilities, net of acquisitions:
    		                                                                                               
      purchase of u.s. government obligations for the satisfaction and discharge of long-term debt
    		      0 0 0 -647,000,000                                                                                      
      cash, cash equivalents, and restricted cash classified as assets held for sale
    		                                                                                               
      net increase in cash, cash equivalents, and restricted cash
    		                                                                                               
      cash, cash equivalents, and restricted cash at beginning of year
    		                                                                                               
      cash, cash equivalents, and restricted cash at end of year
    		                                                                                               
      less: restricted cash at end of year included in prepaid expenses and other
    		                                                                                               
      cash and cash equivalents at end of year
    		                                                                                               
      supplemental cash flow information
    		                                                                                               
      cash paid for:
    		                                                                                               
      interest
    		                                                                                               
      income taxes, net of refunds
    		                                                                                               
      european businesses held for sale
    		            -55,000,000 20,000,000 238,000,000 801,000,000                                                                                
      payments for debt extinguishments
    		              0 0                                                                                
      exercise of put right by noncontrolling shareholders of mckesson europe ag
    		              0 0 0 -1,031,000,000                                                                              
      goodwill and long-lived asset impairment charges
    		              47,000,000 1,000,000                                                                                
      cash, cash equivalents, and restricted cash classified within assets held for sale
    		              -325,000,000                                                                                 
      change in cash, cash equivalents, and restricted cash classified within assets held for sale
    		           0 0 470,000,000                                                                                  
      equity earnings and charges from investment in change healthcare joint venture
    		                      -394,000,000 28,000,000                                                                        
      income from sales of businesses and investments
    		                     2,000,000                                                                          
      goodwill and other asset impairment charges
    		                  6,000,000 132,000,000 99,000,000 5,000,000 26,000,000 101,000,000 7,000,000 5,000,000 1,408,000,000 60,000,000                                                                    
      (gain) income from sales of businesses and investments
    		                                                                                               
      share repurchases, including shares surrendered for tax withholding
    		                  -244,000,000 -254,000,000 -248,000,000 -24,000,000 -3,000,000 -499,000,000 -751,000,000 -701,000,000 -251,000,000 -500,000,000 -581,000,000 -307,000,000 -758,000,000 -250,000,000 -401,000,000 -300,000,000 -251,000,000 -2,002,000,000 0 -58,000,000 -652,000,000 -355,000,000 -500,000,000 -105,000,000 -344,000,000 -1,000,000 -3,000,000 -102,000,000 -2,000,000 0 -1,000,000 -127,000,000 -801,000,000 -360,000,000 0 -53,000,000             -151,000,000 0 0 -147,000,000                          
      payments for property, plant and equipment
    		                     -72,000,000 -120,000,000 -116,000,000 -39,000,000 -87,000,000 -117,000,000 -131,000,000 -77,000,000 -101,000,000 -136,000,000 -105,000,000 -89,000,000 -75,000,000 -158,000,000 -95,000,000 -75,000,000 -76,000,000                                                          
      acquisitions, net of cash, cash equivalents and restricted cash acquired
    		                     -4,000,000 -36,000,000 -2,000,000 -49,000,000 -46,000,000 -39,000,000 -26,000,000 -14,000,000 -826,000,000                                                                  
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		                     -28,000,000 -46,000,000 5,000,000 4,000,000 18,000,000 11,000,000 -43,000,000 -9,000,000 -78,000,000                                                                  
      net decrease in cash, cash equivalents and restricted cash
    		                     -1,159,000,000  709,000,000 -591,000,000 -1,034,000,000  -269,000,000 -81,000,000 -473,000,000                                                                  
      cash, cash equivalents and restricted cash at beginning of period
    		                     4,023,000,000  0 0 2,981,000,000  0 0 2,672,000,000                                                                  
      cash, cash equivalents and restricted cash at end of period
    		                     2,864,000,000  709,000,000 -591,000,000 1,947,000,000  -269,000,000 -81,000,000 2,199,000,000                                                                  
      gain on healthcare technology net asset exchange
    		                                                                                               
      proceeds from sale of businesses and investments
    		                          20,000,000 35,000,000                                                                    
      payments received on healthcare technology net asset exchange
    		                              0 0                                                                
      net increase in cash, cash equivalents and restricted cash
    		                                                                                               
      cash, cash equivalents and restricted cash at beginning of year
    		                                                                                               
      cash, cash equivalents and restricted cash at end of year
    		                                                                                               
      depreciation and amortization
    		                       228,000,000 234,000,000 229,000,000  239,000,000 240,000,000 235,000,000  234,000,000 236,000,000 227,000,000  204,000,000 217,000,000 242,000,000  220,000,000 222,000,000 229,000,000  250,000,000 259,000,000 284,000,000  159,000,000 162,000,000 154,000,000  146,000,000 142,000,000 140,000,000  137,000,000 136,000,000 135,000,000  114,000,000 118,000,000 120,000,000  126,000,000 113,000,000 111,000,000  112,000,000 112,000,000 106,000,000  93,000,000 89,000,000 89,000,000  69,000,000 69,000,000 70,000,000  71,000,000 63,000,000 64,000,000              
      loss (income) from equity method investment in change healthcare joint venture
    		                         -4,000,000                                                                      
      income from equity method investment in change healthcare
    		                          32,000,000 50,000,000 56,000,000 56,000,000 -23,000,000 90,000,000 61,000,000 120,000,000                                                              
      settlement payment
    		                                                                                               
      gain from sale of businesses and investments
    		                                                                                               
      changes in operating assets and liabilities, net of acquisitions:
    		                                                                                               
      goodwill and asset impairment charges
    		                             610,000,000                                                                  
      charges (credits) associated with last-in-first-out inventory method
    		                             -21,000,000     144,000,000                                                             
      share-based compensation expense
    		                              12,000,000 0   6,000,000 30,000,000   10,000,000 35,000,000   47,000,000 45,000,000   45,000,000 42,000,000   44,000,000 41,000,000 40,000,000 42,000,000 41,000,000 35,000,000 39,000,000 39,000,000 38,000,000 33,000,000 33,000,000 33,000,000 31,000,000 30,000,000 29,000,000 24,000,000 27,000,000 19,000,000 25,000,000 28,000,000 18,000,000 26,000,000                        
      gain from sales of businesses and equity investments
    		                                                                                               
      deferred revenue
    		                              -9,000,000 4,000,000 -65,000,000 -73,000,000 -29,000,000 196,000,000 -141,000,000 -113,000,000 -54,000,000 192,000,000 -132,000,000 -126,000,000 -122,000,000 232,000,000 -117,000,000 -134,000,000 -56,000,000 231,000,000 -104,000,000 -107,000,000 -74,000,000 -98,000,000 249,000,000 -102,000,000 -56,000,000 -69,000,000 241,000,000 -50,000,000 -40,000,000 260,000,000 -109,000,000 -69,000,000 -30,000,000 251,000,000 -110,000,000 -84,000,000 -143,000,000 240,000,000 -99,000,000 -53,000,000 -12,000,000 200,000,000 -53,000,000 -37,000,000 -59,000,000 228,000,000 -13,000,000 25,000,000 72,000,000 206,000,000 -28,000,000 129,000,000 -18,100,000 181,800,000 -40,000,000 -35,300,000 -1,000,000 130,100,000 -11,900,000 -36,500,000 -41,700,000 114,100,000 -14,200,000 -7,500,000  
      acquisitions, net of cash and cash equivalents acquired
    		                              -914,000,000 -105,000,000 -389,000,000 -1,485,000,000 -63,000,000 -2,133,000,000 -222,000,000 -1,819,000,000 -15,000,000 -14,000,000 -5,000,000 -6,000,000 -130,000,000 -9,000,000 -17,000,000 -14,000,000                                                  
      proceeds from sale of businesses and other assets
    		                                                                                               
      restricted cash for acquisitions
    		                              0 0 0 1,469,000,000 -1,441,000,000 0 0 935,000,000                                                          
      effect of exchange rate changes on cash and cash equivalents
    		                              7,000,000 34,000,000 34,000,000 75,000,000 15,000,000 -107,000,000 -40,000,000 -12,000,000 71,000,000 -52,000,000 -34,000,000 60,000,000 -175,000,000 -65,000,000 -88,000,000 9,000,000 30,000,000 -4,000,000 12,000,000 -10,000,000 -14,000,000 -4,000,000    20,000,000   2,000,000 14,000,000 4,000,000 -12,000,000 2,000,000 2,000,000 15,000,000 17,000,000 -15,000,000 -35,000,000 -8,000,000 3,000,000 0 -4,000,000                        
      net decrease in cash and cash equivalents
    		                              53,000,000                       -1,136,000,000    -496,000,000                              -61,100,000 -183,600,000 -76,800,000      
      cash and cash equivalents at beginning of year
    		                                                                                               
      goodwill impairment and other asset impairment charges
    		                               0                                                                
      credits associated with last-in-first-out inventory method
    		                                                                                               
      gain from sale of businesses and equity investments
    		                               -108,000,000                                                                
      proceeds from/ (payments for) sale of businesses and equity investments
    		                               165,000,000                                                                
      cash and cash equivalents at beginning of period
    		                               0 0 2,783,000,000  0 0 4,048,000,000  0 0 5,341,000,000  0 0 4,193,000,000  0 0 2,456,000,000  0 0 3,149,000,000  0 0 3,612,000,000  0 0 3,731,000,000  0 0 2,109,000,000  0 0 1,362,000,000  0 0 1,954,000,000  0 -3,000,000 2,142,000,000  0 0 1,800,000,000  0 0 708,000,000  0 0 522,000,000      
      net increase in cash and cash equivalents
    		                                224,000,000 -444,000,000   805,000,000 611,000,000 642,000,000 -1,953,000,000 -276,000,000 294,000,000 754,000,000 783,000,000 -301,000,000 -88,000,000   55,000,000 449,000,000  -105,000,000   -1,042,000,000 248,000,000   399,000,000 163,000,000 -215,000,000 -466,000,000 303,000,000 213,000,000 571,000,000 535,000,000   -64,000,000 -175,000,000   315,000,000 249,000,000 -59,000,000 -241,000,000 257,000,000 -142,000,000 -41,000,000 -813,000,000 587,000,000 609,000,000 767,100,000 36,700,000 159,500,000 128,700,000          
      charges associated with last-in-first-out inventory method
    		                                 26,000,000   -43,000,000 47,000,000 29,000,000 33,000,000 91,000,000 91,000,000 50,000,000 95,000,000 94,000,000 98,000,000 125,000,000                                                 
      gain from sale of businesses
    		                                 -1,000,000  0                                                            
      proceeds from/(payments for) sale of businesses
    		                                 3,000,000                                                              
      goodwill and other impairment charges
    		                                                                                               
      gain from sales of businesses
    		                                     113,000,000 0                                                         
      claim and litigation charges
    		                                                                                               
      litigation settlement payment
    		                                                                                               
      proceeds from/(payment for) sale of businesses and other assets
    		                                                                                               
      payment received on healthcare technology net asset exchange
    		                                                                                               
      goodwill impairment charge
    		                                   0                                                            
      proceeds from/(payment for) sale of businesses
    		                                   7,000,000 3,000,000 -101,000,000                                                          
      impairment charges and impairment of equity investment
    		                                                                                               
      litigation settlement payments
    		                                              -19,000,000 -66,000,000 0 -20,000,000 -13,000,000 -32,000,000 -165,000,000 -273,000,000 0    0    0                                 
      proceeds from sale of businesses and equity investment
    		                                          0                                                     
      non-cash item:
    		                                                                                               
      fair value of debt assumed on acquisitions
    		                                                                                               
      conversion of celesio’s convertible bonds to equity
    		                                                                                               
      property acquisitions
    		                                       -94,000,000 -101,000,000 -77,000,000 -90,000,000 -95,000,000 -105,000,000 -86,000,000 -86,000,000 -57,000,000 -63,000,000 -68,000,000 -95,000,000 -65,000,000 -40,000,000 -46,000,000 -55,000,000 -44,000,000 -68,000,000 -58,000,000 -76,000,000 -50,000,000 -55,000,000 -52,000,000 -62,000,000 -44,000,000 -51,000,000 -42,000,000 -44,000,000 -71,000,000 -40,000,000 -40,000,000 -66,000,000 -46,000,000 -48,000,000 -35,000,000 -50,000,000 -25,000,000 -25,000,000 -26,000,000 -29,000,000 -55,000,000 -39,000,000 -44,000,000 -49,000,000 -36,700,000 -31,300,000 -22,900,000 -43,400,000 -25,100,000 -16,200,000 -30,300,000 -34,200,000 -25,900,000 -29,400,000 -26,500,000 -57,000,000 
      proceeds from sale of businesses
    		                                       0                                   4,000,000 0                    
      gain from the sale of businesses
    		                                                                                               
      proceeds from sale of business
    		                                         84,000,000                  0                    0    0 0 12,300,000          
      gain on business combination
    		                                                  0 0 0 -81,000,000                                          
      litigation charges
    		                                              0 18,000,000   12,000,000 0   4,000,000 27,000,000                                        
      other deferred taxes
    		                                                 98,000,000 107,000,000 248,000,000 81,000,000 170,000,000         88,000,000    244,000,000                             
      impairment of an equity investment
    		                                                                                               
      proceeds from sales of business and equity investment
    		                                                                                               
      fair value of debt assumed on acquisition
    		                                                                                               
      acquisitions, less cash and cash equivalents acquired
    		                                               0 -42,000,000 -74,000,000  -326,000,000 -143,000,000 -108,000,000                                          
      discontinued operation – gain on sale, net of tax
    		                                                           0                                    
      impairment of capitalized software held for sale
    		                                                                                               
      restricted cash for litigation charges
    		                                                                                               
      deferred tax benefit on litigation
    		                                                                                               
      deferred tax benefit on litigation charges
    		                                                     100,000,000  -1,000,000                                        
      deferred tax (benefit) expense on litigation
    		                                                                                               
      asset impairment charge – capitalized software held for sale
    		                                                           0                                    
      repayments of debt
    		                                                       -6,000,000 -1,000,000 -16,000,000                                      
      common stock repurchases, including shares surrendered for tax withholding
    		                                                         -672,000,000    -1,016,000,000    -298,000,000                              
      common stock issuances
    		                                                       40,000,000    44,000,000                                    
      changes in operating assets and liabilities, net of business acquisitions:
    		                                                                                               
      acquisitions of businesses, less cash and cash equivalents acquired
    		                                                          0    0 -12,000,000   -38,000,000 0 -78,000,000 -242,000,000 -18,000,000 -541,000,000 -29,000,000 -22,000,000 -1,832,000,000 -11,000,000 -4,000,000 -91,000,000 -29,000,000 1,000,000 -567,000,000 -8,000,000 -23,200,000 -38,100,000 -10,200,000 -37,400,000    -600,000      
      common stock share repurchases, including shares surrendered for tax withholding
    		                                                           -1,000,000    0                                
      changes in operating assets and liabilities, net of business acquisition:
    		                                                                                               
      acquisition of business, less cash and cash equivalents acquired
    		                                                         -105,000,000                                      
      common stock transactions – other
    		                                                         72,000,000        31,000,000                              
      discontinued operation — gain on sale, net of tax
    		                                                                                               
      impairment of investments
    		                                                                                               
      litigation charge
    		                                                          0                                     
      restricted cash for litigation charge
    		                                                              0                                 
      share repurchases, retirements
    		                                                                  0 0                            
      fair value of acquisition debt assumed
    		                                                          19,000,000                                     
      changes in operating assets and liabilities, net of effect of acquisitions:
    		                                                                                               
      deferred tax expense on litigation credit
    		                                                                                               
      changes in operating assets and liabilities:
    		                                                                                               
      common stock transactions — other
    		                                                             144,000,000  10,000,000                                
      discontinued operations, net of income taxes
    		                                                                      -2,000,000 0   0 -3,000,000                    
      litigation charge (credit)
    		                                                                                               
      repayment of long-term debt
    		                                                                  -1,000,000 -1,000,000 0 -2,000,000                          
      income tax reserve reversals
    		                                                                  -22,000,000 0                            
      impact of accounts receivable sales facility
    		                                                                   -147,000,000 172,000,000 325,000,000                          
      deferred tax
    		                                                                                               
      common stock transactions — issuances
    		                                                               51,000,000                                
      common stock share repurchases, retirements
    		                                                                                               
      proceeds from short-term borrowing
    		                                                                 5,000,000    558,000,000                          
      litigation charge (credits)
    		                                                                                               
      deferred taxes (benefits) on litigation charge (credits)
    		                                                                                               
      excess tax benefit from share-based payment arrangements
    		                                                                                               
      consolidated securities litigation action settlement payments
    		                                                                                               
      capital stock transactions:
    		                                                                                               
      excess tax benefits from share-based payment arrangements
    		                                                                  16,000,000 -1,000,000 -4,000,000 -3,000,000  -28,000,000                        
      deferred taxes (benefits) on litigation charge (credit)
    		                                                                                               
      total
    		                                                                   437,000,000    429,000,000    302,000,000 335,000,000 324,000,000 449,000,000 498,000,000 260,000,000 270,000,000 347,000,000 117,500,000 168,300,000 337,800,000          
      restricted cash for consolidated securities litigation action
    		                                                                      0                         
      esop notes and guarantees
    		                                                                   1,000,000 -1,000,000 2,000,000 2,000,000 1,000,000 0 8,000,000 0 3,000,000 5,000,000 2,000,000 0 3,000,000 6,000,000 3,000,000 0 2,900,000 1,000,000 12,500,000 100,000 3,300,000 900,000 4,900,000 0 9,000,000 800,000 3,000,000  
      securities litigation charge (credit)
    		                                                                          0 0                    
      securities litigation settlement payments
    		                                                                          0 -19,000,000 0 -6,000,000 -16,000,000 -158,000,000 -38,000,000 -31,000,000              
      proceeds from sale of notes receivable
    		                                                                              32,000,000 0   0 20,800,000 17,500,000 21,000,000 3,200,000 7,000,000   0     
      proceeds from issuances of debt
    		                                                                                               
      repayment of debt
    		                                                                      -153,000,000 -1,000,000 0 -8,000,000 -1,020,000,000 -3,000,000 -5,000,000 -3,000,000 -1,000,000 -3,000,000 -9,000,000 -11,000,000 -250,700,000 -3,300,000 -1,400,000 -12,900,000 -6,800,000 -3,900,000 -1,400,000 -5,400,000 -1,900,000 -134,600,000 -1,500,000 -4,500,000 -177,100,000 
      excess tax benefits from share-based arrangements
    		                                                                                               
      supplemental information:
    		                                                                                               
      non-cash transaction:
    		                                                                                               
      common stock issued in conjunction with redemption of long-term debt
    		                                                                                               
      securities litigation credits
    		                                                                                               
      consolidated securities litigation action settlement
    		                                                                                               
      securities litigation credit
    		                                                                                               
      restricted cash
    		                                                                                               
      income taxes
    		                                                                                               
      effects of changes in:
    		                                                                                               
      securities litigation charge
    		                                                                                               
      securities litigation charges
    		                                                                                               
      notes receivable reserve
    		                                                                                               
      customer settlement reserve reversal
    		                                                                                               
      securities litigation charge, net of tax
    		                                                                               0 0 35,000,000              
      capital stock transactions
    		                                                                                               
      income from continuing operations
    		                                                                                154,000,000 170,000,000     214,200,000 120,200,000 156,500,000 155,600,000 181,600,000 134,300,000   125,400,000 
      proceeds from issuance of debt
    		                                                                                     23,400,000  82,600,000    -252,000,000   378,400,000 
      international contract loss accruals
    		                                                                                               
      net cash from continuing operations
    		                                                                                               
      discontinued operations
    		                                                                                          400,000 -100,000 -200,000 -600,000  
      adjustments to reconcile to net cash provided (used) by operating activities:
    		                                                                                               
      securities litigation charge, net of deferred tax benefit
    		                                                                                               
      deferred taxes on income
    		                                                                                   -90,500,000 15,300,000 107,200,000 -69,700,000 13,200,000 87,000,000 39,000,000 107,900,000 4,800,000 8,000,000 5,900,000  
      net cash provided (used) by operating activities
    		                                                                                   152,100,000            
      net cash used by investing activities
    		                                                                                   -124,700,000 -58,800,000 -96,800,000          
      notes receivable
    		                                                                                               
      capital stock transactions issuances
    		                                                                                               
      notes receivable issuances
    		                                                                                     -28,000,000 2,000,000 -36,800,000 29,600,000 -3,600,000 -13,300,000 -23,500,000 -8,500,000 -10,400,000 -12,400,000 
      net cash provided (used) by financing activities
    		                                                                                     97,200,000          
      contract loss accruals
    		                                                                                               
      loss on sales of businesses
    		                                                                                               
      cash paid (received) for:
    		                                                                                               
      acquisitions of businesses, less cash and equivalents acquired
    		                                                                                       -38,300,000        
      dividends paid on convertible preferred securities of subsidiary trust
    		                                                                                        -2,500,000 -2,500,000 -2,500,000 -2,500,000 -2,500,000 -2,500,000 -2,500,000 
      adjustments to reconcile to net cash provided (used) by operating activities
    		                                                                                               
      adjustments to reconcile to net cash from operating activities
    		                                                                                               
      accounts and drafts payable
    		                                                                                           -32,300,000 20,000,000 -5,000,000  
      acquisitions of businesses, less cash and short-term investments acquired
    		                                                                                             -1,900,000 -62,400,000 
      net decrease in cash and equivalents
    		                                                                                           15,800,000 10,600,000 -268,100,000  
      cash and equivalents at beginning of period
    		                                                                                           0 -100,000 557,900,000  
      cash and equivalents at end of period
    		                                                                                           15,800,000 10,500,000 289,800,000  
      1.
    		                                                                                               
      net cash provided (used) by continuing operations
    		                                                                                               
      see financial notes.
    		                                                                                               
      5
    		                                                                                               
      adjustments to reconcile to net cash used by operating activities
    		                                                                                               
      securities litigation costs incurred
    		                                                                                               
      loss on investments
    		                                                                                               
      restructuring and related asset impairments
    		                                                                                               
      total pre-tax special charges
    		                                                                                               
      income tax benefit
    		                                                                                               
      total after-tax special charges
    		                                                                                               
      diluted loss (credit) per share attributable to special charges
    		                                                                                               
      proceeds from sales of businesses
    		                                                                                               
      reported net income
    		                                                                                               
      goodwill amortization, net of tax
    		                                                                                               
      adjusted net income
    		                                                                                               
      diluted earnings per common share
    		                                                                                               
      adjusted diluted earnings per common share
    		                                                                                               
      basic earnings per common share
    		                                                                                               
      adjusted basic earnings per common share
    		                                                                                               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.